top of page

Disseminating the knowledge

CardioCel 2012-2021

February 2023

A presentation summarising all the studies about the performance of CardioCel when used for the repair of congenital heart defects from 2012 to 2022 given at a dinner meeting in Melbourne.

Melbourne Cityscape

ICOR

April 2021

An overview of ICOR presented by Nelson Alphonso

Conference proceedings

Mid-term outcome of repair of congenital heart defects using CardioCel

June 2016

Poster presentation. 4th Joint Meeting, ECHSA & CHSS; Venice, Italy
June 2016

HERO_Venice__FloatingCityBuilt_iStock-986940360.jpeg

CardioCel: mid-term outcomes and histopathology

November 2016

Children’s Health Queensland, Annual Research Symposium; Brisbane
November 2016

®CFJ_CCHR-63_feature.jpg

Tissue engineered bovine pericardium (CardioCel) for repair of congenital heart defects: histopathology and outcomes at mid-term follow up

November 2016

Australia New Zealand Society of Cardiothoracic Surgery, Annual Scientific Meeting; Cairns
November 2016

Image by Manny Moreno

Durability of tissue-engineered bovine pericardium (CardioCel) when used for the repair of congenital heart defects at 24 months or longer follow-up

July 2017

7th World Congress of Pediatric Cardiology and Cardiac Surgery, Barcelona
16-21 July 2017

Image by Tomáš Nožina

Multi-centre experience with 500 CardioCel® implants when used for the repair of congenital heart defects

February 2018

64th Annual Conference – Indian Association of Cardiovascular and Thoracic Surgeons. Visakhapatnam
1-4 February 2018

Image by Vizag Explore

Single-centre experience with tissue engineered bovine pericardium (CardioCel®) used for the repair of congenital heart defects

August 2018

CSANZ Annual Scientific Meeting 2018
Brisbane from 2 - 5 August 2018

Image by ROMAIN TERPREAU

Multi-center clinical outcomes for 830 implants of tissue engineered bovine pericardium (CardioCel®) used for the repair of congenital heart defects

September 2018

The 7th Congress of Asia Pacific Pediatric Cardiac Society. Bali, Indonesia
30 August – 2 September 2018

Image by Alec Favale

Australia-wide experience CardioCel® for the repair of congenital heart defectse

November 2018

ANZSCTS Annual Scientific Meeting
Noosa, QLD. 8-11 November 2018

Image by Luisa Denu

CardioCel® for the Repair of Congenital Heart Defects: An Australian Single-Centre Experience

August 2021

CSANZ 2021 Annual Scientific Meeting
Virtual Meeting 6-7 August 2021

Image by rawkkim

CardioCel Experience in Surgery for Congenital Heart Defects: Past, Present and Future

May 2021

An invited APAC webinar presented by Prem Venugopal, Director of Cardiac Surgery at the Queensland Children's Hospital, Nelson Alphonso Deputy Director of Cardiac Surgery at the Queensland Children's Hospital, Sivakumar Sivalingam, Clinical Director of Congenital Heart Surgery at the National Heart Institute, Kuala Lumpur and Supreet Marathe, Senior Surgical Fellow and Academic Lead for Cardiac Surgery at the Queensland Children's Hospital.

ICOR presentation flyer.JPG

CardioCel membrane for repair of CHD:
Australia-wide results for >1000 implants

October 2022

An assessment of the mid-term performance of CardioCel in the repair of congenital heart defects (CHD) using retrospective data from three Australian paediatric cardiac centres from October 2012 to December 2019

EACTS 2023.png

©2022 by the ICOR project team. Proudly created with Wix.com

bottom of page